SIGNET RING CELL ADENOCARCINOMA

Clinical trials for SIGNET RING CELL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new SIGNET RING CELL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for SIGNET RING CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Cancer-Killing virus plus immunotherapy shows promise for rare skin tumors

Disease control Ongoing

This study tests a two-step treatment for people with rare skin cancers or certain lymphomas that haven't responded to standard therapy. First, patients receive a virus-based drug (talimogene laherparepvec) injected directly into tumors to help the immune system recognize and att…

Matched conditions: SIGNET RING CELL ADENOCARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 01, 2026 16:00 UTC

SIGNET RING CELL ADENOCARCINOMA

Get alerted when new SIGNET RING CELL ADENOCARCINOMA trials appear

Cancer-Killing virus plus immunotherapy shows promise for rare skin tumors